Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails
This study has been completed.
Study NCT00648986   Information provided by Columbia University
First Received: March 27, 2008   Last Updated: April 1, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Brittle Nails
Interventions listed in this trial
Tazorac
Additional drug interventions recognized in this trial
Tazarotene
More general drug interventions related to this trial
Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Columbia University
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services